BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRCA1
,
glucose metabolic process
,
Pseudomonas infection
,
Retina
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
vital%202
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for vital%202
Explore Curated Studies Results
Literature
Most Relevant Literature
Vascular Access Perception and Quality of Life of Haemodialysis Patients.
Five-year results of vital pulp therapy in permanent molars with irreversible pulpitis: a non-inferi…
Influencing factors and spatiotemporal heterogeneity of livestock greenhouse gas emission: Evidence …
Dose and image quality at CT pulmonary angiography-comparison of first and second generation dual-en…
Contemporary review of exercise in heart transplant recipients.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety, Tolerability, Pharmacokinetics (Including Food Interaction), and Pharmacodynamics of BIA 3-2…
Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and Metabolites
Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin
Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Ca…
Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fa…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ